Cheap drug could cut blood loss in face surgery

NCT ID NCT07392034

Completed Disease control Sponsor: Nishtar Medical University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This phase 2 trial tested whether a single dose of tranexamic acid, given before surgery, can reduce blood loss in people undergoing maxillofacial trauma surgery. Sixty patients were randomly assigned to receive either the drug or a placebo. The study measured blood loss, hemoglobin drop, and the need for transfusions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: tranexamic acid (TXA)
What this could lead to: If it works, this could provide a simple, cheap way to reduce bleeding and the need for blood transfusions during facial surgery.
What could go wrong: This is a small, early-phase trial with only 60 participants. Results may not apply to all patients, and the drug may not show a meaningful benefit over placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates